Despite the scarcity of ESR1 mutations in primary ER+ breast cancer, several lines of evidence suggest that ESR1-mutated clones may be identified in primary tumors by droplet digital PCR (ddPCR)14–16. The gene discussed is ESR1; the disease is breast carcinoma.